Saturn V Capital Management Lp Top Holdings and 13F Report (2024)

→ Discover How to Turn $10,000 into $1 Million (From Paradigm Press) (Ad)

About Saturn V Capital Management Lp

Investment Activity

Saturn V Capital Management Lp has $249.42 million in total holdings as of March 31, 2024.
Saturn V Capital Management Lp owns shares of 21 different stocks, but just 13 companies or ETFs make up 80% of its holdings.
Approximately 28.64% of the portfolio was purchased this quarter.
About 40.54% of the portfolio was sold this quarter.
This quarter, Saturn V Capital Management Lp has purchased 23 new stocks and bought additional shares in 5 stocks.
Saturn V Capital Management Lp sold shares of 10 stocks and completely divested from 7 stocks this quarter.

Largest Holdings

Crinetics Pharmaceuticals: $30,901,294
argenx: $25,826,851
Cytokinetics: $18,488,077
KalVista Pharmaceuticals: $17,101,551
Merus: $16,959,604

Largest New Holdings this Quarter

Vaxcyte: $12,649,304 Holding
ABIVAX SA: $8,908,471 Holding
Ironwood Pharmaceuticals: $8,230,184 Holding
Geron: $3,709,184 Holding
Cabaletta Bio: $2,954,331 Holding

Largest Purchases this Quarter

Vaxcyte: 185,175 shares (about $12.65M)
Disc Medicine: 190,019 shares (about $11.83M)
ABIVAX SA: 622,970 shares (about $8.91M)
Ironwood Pharmaceuticals: 944,912 shares (about $8.23M)
Amicus Therapeutics: 698,408 shares (about $8.23M)

Largest Sales this Quarter

Cytokinetics: 184,443 shares (about $12.93M)
iTeos Therapeutics: 441,137 shares (about $6.02M)
Crinetics Pharmaceuticals: 126,989 shares (about $5.94M)
Morphic: 126,711 shares (about $4.46M)
KalVista Pharmaceuticals: 365,611 shares (about $4.34M)

Sector Allocation Over Time

Selling

Neutral

Buying

Latest 13F Holdings and Changes Since Previous Quarterly Filing

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
CRNX Crinetics Pharmaceuticals	$30,901,294	$5,944,355 ▼	-16.1%	660,143	12.4%	Medical
ARGX argenx	$25,826,851	$5,678,230 ▲	28.2%	65,597	10.4%	Medical
CYTK Cytokinetics	$18,488,077	$12,931,299 ▼	-41.2%	263,701	7.4%	Medical
KALV KalVista Pharmaceuticals	$17,101,551	$4,336,147 ▼	-20.2%	1,441,952	6.9%	Medical
MRUS Merus	$16,959,604	$572,061 ▼	-3.3%	376,629	6.8%	Medical
IRON Disc Medicine	$15,864,035	$11,830,583 ▲	293.3%	254,803	6.4%	Medical
ASND Ascendis Pharma A/S	$15,635,211	$4,282,797 ▼	-21.5%	103,428	6.3%	Medical
ANAB AnaptysBio	$13,197,418	$1,762,077 ▼	-11.8%	586,031	5.3%	Medical
PCVX Vaxcyte	$12,649,304	$12,649,304 ▲	New Holding	185,175	5.1%	Medical
COGT Cogent Biosciences	$10,718,541	$5,633,645 ▲	110.8%	1,595,021	4.3%	Medical
FOLD Amicus Therapeutics	$10,582,928	$8,227,246 ▲	349.3%	898,381	4.2%	Medical
BMRN BioMarin Pharmaceutical	$10,409,880		0.0%	119,188	4.2%	Medical
SNDX Syndax Pharmaceuticals	$9,472,329	$2,875,088 ▼	-23.3%	397,997	3.8%	Medical
ABIVAX SA	$8,908,471	$8,908,471 ▲	New Holding	622,970	3.6%	SPONSORED ADS
IRWD Ironwood Pharmaceuticals	$8,230,184	$8,230,184 ▲	New Holding	944,912	3.3%	Medical
PHAT Phathom Pharmaceuticals	$5,320,482	$3,620,485 ▲	213.0%	500,987	2.1%	Medical
ITOS iTeos Therapeutics	$5,279,976	$6,017,109 ▼	-53.3%	387,095	2.1%	Medical
APLS Apellis Pharmaceuticals	$4,200,595	$4,200,654 ▼	-50.0%	71,463	1.7%	Medical
GERN Geron	$3,709,184	$3,709,184 ▲	New Holding	1,123,995	1.5%	Medical
MORF Morphic	$3,014,246	$4,460,227 ▼	-59.7%	85,632	1.2%	Medical
CABA Cabaletta Bio	$2,954,331	$2,954,331 ▲	New Holding	173,173	1.2%	Medical
CBAY CymaBay Therapeutics	$0	$17,720,905 ▼	-100.0%	0	0.0%	Medical
AMLX Amylyx Pharmaceuticals	$0	$16,181,225 ▼	-100.0%	0	0.0%	Medical
BIIB Biogen	$0	$8,402,003 ▼	-100.0%	0	0.0%	Medical
ATXS Astria Therapeutics	$0	$7,608,292 ▼	-100.0%	0	0.0%	Medical
ALNY Alnylam Pharmaceuticals	$0	$1,976,691 ▼	-100.0%	0	0.0%	Medical
JSPR Jasper Therapeutics	$0	$1,093,724 ▼	-100.0%	0	0.0%	Medical
AMBRX BIOPHARMA INC	$0	$751,601 ▼	-100.0%	0	0.0%	COM